- Motley Fool•18 hours ago
Management succeeded at building up investors' excitement about the company's future at two healthcare conferences during the month, which caused shares to rally.
- PR Newswire•12 days ago
BOULDER, Colo., Nov. 22, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare conference. The ...
- Insider Monkey•19 days agoIs Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?
Despite of all the negative sentiment looming around them, hedge funds had a pretty solid run for much of this year, generating positive returns for seven or eight consecutive months (depending on the source) before that streak came to an end in October. The third-quarter was a particularly strong one for the industry, as evidenced […]
ARRY : Summary for Array BioPharma Inc. - Yahoo Finance
Array BioPharma Inc. (ARRY)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||8.10 x 300|
|Ask||8.36 x 300|
|Day's Range||7.82 - 8.30|
|52 Week Range||2.38 - 8.30|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-11.73|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|